Market News

In his first ever tweet, Goldman Sachs CEO Lloyd Blankfein condemned Trump's move stating it was "a setback for the environment and the U.S.'s leadership position in the world."

more...

Meal kit company Blue Apron likes to say that it provides "a better way to cook." But will it provide investors hungry for good food companies a better way to trade? The public market could soon find out: Blue Apron filed for an IPO Thursday afternoon.

more...

Chinese e-commerce giant Alibaba is working aggressively towards an integrated retail model, which its founder Jack Ma refers to as “New Retail.” The company recently invested in a physical supermarket operator, and this note explains why.

more...

The Securities & Exchange Commission is stepping in again on the debate over what standards of conduct should apply to investment advisers.

more...

Stocks are going gangbusters, but some funds—including three I’m going to tell you about below—have gotten way ahead of the market. That means it’s time to sell. Yesterday.

more...

Now that "many" advertisers are back after the YouTube ad noise in March, shouldn't Google estimates be going up?

more...

Closed-end funds (CEFs), by contrast, are virtually an afterthought, and that’s too bad. Because in many cases – including the three high-yield dynamos I want to show you today – they’re a superior source of quality and raw total-return performance.

more...

This article describes a dialogue between a group of LPs (investors in venture funds) and the venture capitalists whose funds they finance and startup founders. The dialogue occurred in the form of a roundtable discussion held in Paris at VentureCrushParis on May 29th.

more...

After the London Stock Exchange's move to bag Citigroup's Yield Book fixed-income analytics service and associated indexing business in a $685 million cash deal, does the LSE's stock merit buying at the current level and post the collapsed merger with Deutsche Boerse in Frankfurt?

more...

The Trump administration’s tax reform is eagerly awaited by the corporate world, as it proposes to lower the corporate tax rate to 15%. But for companies such as Pfizer, there may not be much of an impact. This note explains why.

more...